Major medical device company going through manufacturing footprint rationalization.
Overall project was running late with significant challenges on timelines, plagued with quality & service issues. We were brought in to accelerate the transfer of two lines (COGS- €52M) and develop a sound governing structure for overall transformation initiative.
Extremely pleased with their approach, engagement & quality of resources. They were able to manage this from start –to-finish while giving our team time to focus on a major product launch. We have retained them for transfer from US site also.